Scailyte and MaxiVAX Solve Clinical Challenges with Data-Driven Collaboration

Scailyte is a Swiss-based start-up specialized in generating actionable insights/biosignatures from multi-omics single-cell data using artificial intelligence (AI). Our AI platform, ScaiVision, combines features to integrate different datasets, is indication- and cell-type agnostic and uses data augmentation and a cluster-free approach to extract relevant information while retaining single-cell resolution. These features result in very high discovery success rates from a limited number of samples, with actionable insights for the basis of assay development. 

With a commitment to excellence, Scailyte empowers partners to transform data into actionable intelligence informing  decision making and driving innovation.